CD133+ CS/ICs were found in the center of the primary tumor, whereas CD133+ CXCR4+ CS/ICs were present in the invasive front of pancreatic cancer and determined the metastatic phenotype [48]. This evidence concerns the gene PROM1 and familial pancreatic carcinoma.